Table 1.
Primary | Circulating podocyte-toxic factor |
Secondary: Maladaptive | Reduced number of functioning nephrons (e.g., unilateral renal agenesis, renal dysplasia, oligomeganephronia, glycogen storage disease, low birth weight) |
Abnormal stress on an initially normal nephron population (e.g., morbid obesity, surgical reduction of renal mass [usually >75%], reflux nephropathy, high-protein diet, sickle cell disease, any advanced kidney disease with substantial loss of nephrons) | |
Other causes: sleep apnea, cyanotic congenital heart disease, renal artery stenosis, malignant hypertension, cholesterol emboli | |
Secondary: Viral | HIV (established), CMV (probably), parvovirus B19 (possibly), EBV (possibly), HCV (possibly), hemophagocytic syndrome (possibly) |
Secondary: Drug induced | Direct-acting antiviral therapy (ledipasvir, sofosbuvir), mTOR inhibitors, calcineurin inhibitors, anthracyclines, heroin(adulterants), lithium, IFN, anabolic steroids |
Genetic | Renal limited (Table 2) |
Syndromic (Table 3) | |
Unknown |
CMV, cytomegalovirus; EBV, Epstein-Barr virus; HCV, Hepatitis C virus; mTOR, mammalian target of rapamycin. IFN, interferon